Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: AEZS-108|DRUG: SCCC|DRUG: Dexamethasone
Sponsor: AEterna Zentaris